Work

A chance to prevent Alzheimer's disease sooner than you think

Year: 2024

Type: article

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(23)00508-2

Authors: Eric M Reiman, Jeffrey L Cummings, Jessica B Langbaum, Soeren Mattke, Robert C Alexander

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Biogen, Sage Therapeutics, Prothena, Cardiff University, Eisai, Novo Nordisk, NOMIS Stiftung, H. Lundbeck A/S, Genentech, National Institute on Aging, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke

Awards: Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors, Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease, Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC), Alzheimer's Prevention Initiative ADAD Colombia Trial, Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission, Policy options to improve access to memory care for disadvantaged individuals who are dually eligible for Medicare and Medicaid, Arizona Alzheimer's Disease Research Center, APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease, API A4 Alzheimer's Prevention Trial, Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative

OpenAlex ID: W4391090347

FWCI: 7.311

Cites:

Cited by: 25

Related to: 10